Strategies for developing PD-1 inhibitors and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Strategies for developing PD-1 inhibitors and future directions

Published:2022-08 Issue: Volume:202 Page:115113
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Chen Wensheng,Huang Yuan,Pan Wenting,Xu Meng,Chen Liang

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China National Outstanding Youth Science Fund Project

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference106 articles.

1. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

2. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures;Smith;Nature,1989

3. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J.,1992

4. Structure and chromosomal localization of the human PD-1 gene (PDCD1);Shinohara;Genomics,1994

5. PD-L1 inhibitors: different classes, activities, and mechanisms of action;Surmiak;Int. J. Mol. Sci.,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esterase responsive release of anti-cancer agents from conjugated lipid nanocarrier and the regulatory considerations;Pharmaceutical Patent Analyst;2024-07-16

2. Immune myocarditis induced by sintilimab therapy: A case report;Experimental and Therapeutic Medicine;2024-06-25

3. Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway;Journal of Medicinal Chemistry;2024-04-10

4. Unleashing the power of immune checkpoints: Post-translational modification of novel molecules and clinical applications;Cancer Letters;2024-04

5. Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules;Scientific Reports;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3